A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (ACHIEVE-1)
Type 2 Diabetes
About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria: Have Type 2 Diabetes Have HbA1c ≥7.0% (53 mmol/mol) to ≤9.5% (80 mmol/mol) despite diet and exercise treatment, as determined by the central laboratory at screening. Are naïve to insulin therapy except for gestational diabetes or ≤14 days use for acute treatment and have not used any oral or injectable antihyperglycemic medications during the 90 days preceding screening or between screening and randomization. Are of stable weight (±5%) for at least 90 days prior to screening and agree to not initiate an intensive diet or exercise program during the study with the intent of reducing body weight other than the lifestyle and/or dietary measures for diabetes treatment. Have a body mass index (BMI) ≥23.0 kilogram/square meter (kg/m²) at screening. Exclusion Criteria: Have Type 1 Diabetes Have a history of ketoacidosis or hyperosmolar state or coma within the last 6 months prior to screening, or between screening and randomization. Currently receiving or planning to receive treatment for diabetic retinopathy and/or macular edema Have New York Heart Association functional classification IV congestive heart failure. Have acute or chronic pancreatitis
Sites / Locations
- Syed Research Consultants LlcRecruiting
- Aventiv ResearchRecruiting
- Epic Medical Research - SurpriseRecruiting
- Quality of Life Medical & Research CenterRecruiting
- Neighborhood Healthcare Institute of HealthRecruiting
- National Research Institute - Huntington ParkRecruiting
- Ark Clinical ResearchRecruiting
- National Research Institute - WilshireRecruiting
- Infinity Clinical Research - NorcoRecruiting
- Norcal Endocrinology & Internal MedicineRecruiting
- Connecticut Clinical Research - CromwellRecruiting
- Invictus Clinical Research GroupRecruiting
- Hillcrest Medical ResearchRecruiting
- K2 Medical ResearchRecruiting
- Global Health Research Center, Inc.Recruiting
- West Orange EndocrinologyRecruiting
- Clinical Research AtlantaRecruiting
- Rophe Adult and Pediatric Medicine/SKYCRNGRecruiting
- Family First Medical CenterRecruiting
- American Health Network of IN, LLC
- Tekton Research - WichitaRecruiting
- Alliance for Multispecialty Research, LLCRecruiting
- Revival Research Institute - DearbornRecruiting
- Billings ClinicRecruiting
- Ellipsis Research GroupRecruiting
- Central New York Clinical ResearchRecruiting
- Monroe Biomedical ResearchRecruiting
- Lucas Research - New BernRecruiting
- Alliance for Multispecialty Research, LLCRecruiting
- The Corvallis Clinic, P.C.Recruiting
- Preferred Primary Care Physicians, Preferred Clinical Research-St. ClairRecruiting
- Preferred Primary Care PhysiciansRecruiting
- The Research Center of The UpstateRecruiting
- MDFirst Research, LLCRecruiting
- The Jackson ClinicRecruiting
- Dallas Diabetes Research CenterRecruiting
- Endocrine Ips, PllcRecruiting
- Amir A Hassan, MD, PARecruiting
- Burke Internal Medicine and ResearchRecruiting
- Wannan Medical College Yijishan Hospital
- Luhe Hospital
- Beijing Pinggu District Hospital
- Huizhou Municipal Central Hospital
- Nanyang First People's HospitalRecruiting
- The Second Affiliated Hospital of Zhengzhou University
- Nanjing First Hospital
- The Second Affiliated Hospital of Nanjing Medical UniversityRecruiting
- Dalian Municipal Central Hospital Affiliated of Dalian Medical University
- Jinan Central Hospital
- Pudong New Area People's Hospital Shanghai
- West China Hospital of Sichuan University
- B. J. Medical College & Civil Hospital
- GMERS Medical College and General Hospital
- M S Ramaiah Medical College and Hospitals
- Medstar Speciality Hospital
- BSES MG Hospital
- All India Institute of Medical Sciences (AIIMS) - Nagpur
- Grant Medical Foundation - Ruby Hall Clinic
- Madras Diabetes Research Foundation
- Kumudini Devi Diabetes Research Center
- Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital
- Tokuyama ClinicRecruiting
- Steel Memorial Yawata HospitalRecruiting
- Hasegawa Medical Clinic
- MinamiAkatsukaClinicRecruiting
- Iwamoto Internal Medicine ClinicRecruiting
- Hayashi Diabetes Internal Medicine ClinicRecruiting
- Medical Corporation Yuga Tsuruma Kaneshiro Diabetes ClinicRecruiting
- Medical Corporation Heishinkai OCROM ClinicRecruiting
- The Institute for Adult Disease, Asahi Life FoundationRecruiting
- Tokyo-Eki Center-building ClinicRecruiting
- Fukuwa ClinicRecruiting
- Heishinkai Medical Group ToCROM ClinicRecruiting
- Morinaga Ueno ClinicRecruiting
- Abe ClinicRecruiting
- Unidad de Investigaci�n Cl�nica Cardiometabolica de Occidente
- Centro de Investigacion Medica Integral
- Salud Cardiovascular
- Centro de Investigacion Medica de Occidente, S.C.
- Investigacion En Salud Y Metabolismo S.C / Nutricion Clinica / Unidad de Base de Datos
- PanAmerican Clinical Research - Querétaro - Avenida Antea
- Instituto Veracruzano en Investigación Clínica S.C.
- FAICIC S. de R.L. de C.V.
- Puerto Rico Health InstituteRecruiting
- Advance Medical Research CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
Orforglipron Dose 1
Orforglipron Dose 2
Orforglipron Dose 3
Placebo
Participants will receive orforglipron orally.
Participants will receive orforglipron orally.
Participants will receive orforglipron orally.
Participants will receive placebo orally.